{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:57:33Z","timestamp":1776988653504,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007515","name":"Youth Science Foundation","doi-asserted-by":"crossref","award":["#81101987"],"award-info":[{"award-number":["#81101987"]}],"id":[{"id":"10.13039\/100007515","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Distinguished Young Scientists Foundation","award":["#30725043"],"award-info":[{"award-number":["#30725043"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.canlet.2014.10.013","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T14:23:58Z","timestamp":1413469438000},"page":"646-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"PB","title":["CIP2A cooperates with H-Ras to promote epithelial\u2013mesenchymal transition in cervical-cancer progression"],"prefix":"10.1016","volume":"356","author":[{"given":"Yi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-9345","authenticated-orcid":false,"given":"Peng-Sheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.10.013_bib0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcb.21215","article-title":"Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment","volume":"101","author":"Tse","year":"2007","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.canlet.2014.10.013_bib0015","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1158\/0008-5472.CAN-10-0785","article-title":"Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness","volume":"70","author":"Giannoni","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.10.013_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnci\/djp535","article-title":"Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma","volume":"102","author":"Rasheed","year":"2010","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.canlet.2014.10.013_bib0025","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.10.013_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.10.013_bib0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","article-title":"Epithelial-mesenchymal transitions in development and pathologies","volume":"15","author":"Thiery","year":"2003","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.10.013_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","article-title":"CIP2A inhibits PP2A in human malignancies","volume":"130","author":"Junttila","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.10.013_bib0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11605-012-1828-3","article-title":"CIP2A is a predictor of poor prognosis in colon cancer","volume":"16","author":"Teng","year":"2012","journal-title":"J. Gastrointest. Surg"},{"key":"10.1016\/j.canlet.2014.10.013_bib0055","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1158\/1078-0432.CCR-08-3283","article-title":"CIP2A is associated with human breast cancer aggressivity","volume":"15","author":"Come","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.10.013_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PDM.0b013e318249fd8b","article-title":"CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis","volume":"21","author":"He","year":"2012","journal-title":"Diagn. Mol. Pathol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1245\/s10434-010-1313-8","article-title":"CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis","volume":"18","author":"Dong","year":"2011","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0070","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1038\/onc.2011.599","article-title":"CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes","volume":"31","author":"Niemela","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.10.013_bib0075","first-page":"138","article-title":"[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"10.1016\/j.canlet.2014.10.013_bib0080","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1440-1843.2012.02173.x","article-title":"Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis","volume":"17","author":"Sato","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.canlet.2014.10.013_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jss.2011.09.020","article-title":"Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression","volume":"173","author":"Krantz","year":"2012","journal-title":"J. Surg. Res"},{"key":"10.1016\/j.canlet.2014.10.013_bib0090","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/sj.onc.1205625","article-title":"Cloning and characterization of a novel 90\u2009kDa \u2018companion\u2019 auto-antigen of p62 overexpressed in cancer","volume":"21","author":"Soo Hoo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.10.013_bib0095","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bjc.2011.346","article-title":"Prognostic role of CIP2A expression in serous ovarian cancer","volume":"105","author":"Bockelman","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2014.10.013_bib0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12032-013-0524-9","article-title":"Clinical implications of CIP2A protein expression in breast cancer","volume":"30","author":"Yu","year":"2013","journal-title":"Med. Oncol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4161\/cbt.18922","article-title":"CIP2A overexpression is associated with c-Myc expression in colorectal cancer","volume":"13","author":"Bockelman","year":"2012","journal-title":"Cancer Biol. Ther"},{"key":"10.1016\/j.canlet.2014.10.013_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1074\/jbc.M113.507954","article-title":"Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity","volume":"1","author":"Jeong","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.10.013_bib0115","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00296-013-2711-6","article-title":"CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression","volume":"33","author":"Lee","year":"2013","journal-title":"Rheumatol. Int"},{"key":"10.1016\/j.canlet.2014.10.013_bib0120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2011.04.031","article-title":"Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein","volume":"122","author":"Liu","year":"2011","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0125","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1158\/1078-0432.CCR-12-3439","article-title":"IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma","volume":"19","author":"Sung","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.10.013_bib0130","doi-asserted-by":"crossref","first-page":"e25854","DOI":"10.4161\/onci.25854","article-title":"The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma","volume":"2","author":"Sung","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2014.10.013_bib0135","first-page":"64","article-title":"Cervial cancer","volume":"vol. 2","author":"Masters","year":"1999"},{"key":"10.1016\/j.canlet.2014.10.013_bib0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.oraloncology.2012.01.012","article-title":"CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2159-8290.CD-12-0292","article-title":"Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1","volume":"3","author":"Laine","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.canlet.2014.10.013_bib0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00432-014-1596-4","article-title":"Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism","volume":"140","author":"Wang","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2014.10.013_bib0155","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.18632\/oncotarget.2127","article-title":"Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands","volume":"5","author":"De","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2014.10.013_bib0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/carcin\/bgt395","article-title":"Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer","volume":"35","author":"Liu","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2014.10.013_bib0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/ml400341k","article-title":"Ethoxysanguinarine induces inhibitory effects and downregulates CIP2A in lung cancer cells","volume":"5","author":"Liu","year":"2014","journal-title":"ACS. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2014.10.013_bib0170","doi-asserted-by":"crossref","first-page":"e73348","DOI":"10.1371\/journal.pone.0073348","article-title":"Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells","volume":"8","author":"Cantini","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.10.013_bib0175","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1038\/onc.2010.357","article-title":"CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells","volume":"29","author":"Chen","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.10.013_bib0180","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1091\/mbc.E12-12-0891","article-title":"Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions","volume":"24","author":"Jung","year":"2013","journal-title":"Mol. Biol. Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514006016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514006016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T08:58:41Z","timestamp":1538125121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383514006016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0304383514006016"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.10.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CIP2A cooperates with H-Ras to promote epithelial\u2013mesenchymal transition in cervical-cancer progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}